K.J. Harrison & Partners Inc Sells 30,160 Shares of SPDR S&P Biotech ETF $XBI

K.J. Harrison & Partners Inc cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 94.6% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 1,720 shares of the exchange traded fund’s stock after selling 30,160 shares during the quarter. K.J. Harrison & Partners Inc’s holdings in SPDR S&P Biotech ETF were worth $220,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Avoro Capital Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $256,053,000. Wells Fargo & Company MN boosted its holdings in SPDR S&P Biotech ETF by 75.7% during the fourth quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after acquiring an additional 1,536,122 shares during the period. OMERS ADMINISTRATION Corp boosted its holdings in SPDR S&P Biotech ETF by 42,425.2% during the fourth quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock valued at $145,147,000 after acquiring an additional 1,187,907 shares during the period. Morgan Stanley grew its position in shares of SPDR S&P Biotech ETF by 8.3% in the fourth quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock valued at $1,401,181,000 after purchasing an additional 882,718 shares during the last quarter. Finally, Assetmark Inc. grew its position in shares of SPDR S&P Biotech ETF by 1,042,265.6% in the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after purchasing an additional 635,782 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $160.46 on Monday. SPDR S&P Biotech ETF has a 52 week low of $83.02 and a 52 week high of $160.82. The firm has a market capitalization of $10.85 billion, a PE ratio of 11.47 and a beta of 0.82. The business’s 50-day simple moving average is $137.41 and its 200-day simple moving average is $130.02.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.